{"entity":{"type":"insider","cik":"0001339402","url":"/insider/0001339402","json_url":"/insider/0001339402.json","name":"Driscoll Martin J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":31,"first":"2006-05-15","last":"2020-11-23","span_basis":"filed_date"},"name_variants":[{"name":"Driscoll Martin J","source":"filing","n_filings":31,"first_seen":"2006-05-15","last_seen":"2020-11-23"}],"transactions":[{"id":2791801,"accession":"0000905718-20-001131","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905718-20-001131","line_url":"/filing/0000905718-20-001131#line-3","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"F-star Therapeutics, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":175.0,"shares_display":"175","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":833.0,"total_display":"833.00","shares_owned_after":47425.0,"shares_owned_after_display":"47,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-20","filed_date":"2020-11-23","scope":"insider"},{"id":8241162,"accession":"0001209191-19-056502","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-056502","line_url":"/filing/0001209191-19-056502#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.83,"price_display":"2.83","price_state":"stated","total_value":14150.0,"total_display":"14,150.00","shares_owned_after":90400.0,"shares_owned_after_display":"90,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-13","filed_date":"2019-11-14","scope":"insider"},{"id":8567196,"accession":"0001209191-19-033137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-033137","line_url":"/filing/0001209191-19-033137#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.03,"price_display":"6.03","price_state":"stated","total_value":60300.0,"total_display":"60,300.00","shares_owned_after":85400.0,"shares_owned_after_display":"85,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-29","filed_date":"2019-05-29","scope":"insider"},{"id":7926842,"accession":"0001209191-19-031916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-031916","line_url":"/filing/0001209191-19-031916#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.63,"price_display":"6.63","price_state":"stated","total_value":33150.0,"total_display":"33,150.00","shares_owned_after":75400.0,"shares_owned_after_display":"75,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-21","filed_date":"2019-05-22","scope":"insider"},{"id":7871073,"accession":"0001209191-19-026537","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-026537","line_url":"/filing/0001209191-19-026537#line-2","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.36,"price_display":"7.36","price_state":"stated","total_value":36800.0,"total_display":"36,800.00","shares_owned_after":70400.0,"shares_owned_after_display":"70,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-30","filed_date":"2019-04-30","scope":"insider"},{"id":7871068,"accession":"0001209191-19-026537","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-026537","line_url":"/filing/0001209191-19-026537#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.31,"price_display":"7.31","price_state":"stated","total_value":36550.0,"total_display":"36,550.00","shares_owned_after":65400.0,"shares_owned_after_display":"65,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-30","filed_date":"2019-04-30","scope":"insider"},{"id":6726714,"accession":"0001209191-18-046392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-046392","line_url":"/filing/0001209191-18-046392#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":12.02,"price_display":"12.02","price_state":"stated","total_value":48080.0,"total_display":"48,080.00","shares_owned_after":60400.0,"shares_owned_after_display":"60,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-13","filed_date":"2018-08-13","scope":"insider"},{"id":6758565,"accession":"0001209191-18-014937","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-014937","line_url":"/filing/0001209191-18-014937#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":12.83,"price_display":"12.83","price_state":"stated","total_value":12830.0,"total_display":"12,830.00","shares_owned_after":56400.0,"shares_owned_after_display":"56,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-28","filed_date":"2018-03-01","scope":"insider"},{"id":5282156,"accession":"0001209191-17-052800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-052800","line_url":"/filing/0001209191-17-052800#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":14.84,"price_display":"14.84","price_state":"stated","total_value":14840.0,"total_display":"14,840.00","shares_owned_after":55400.0,"shares_owned_after_display":"55,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-14","filed_date":"2017-09-14","scope":"insider"},{"id":5070794,"accession":"0001209191-17-047285","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-047285","line_url":"/filing/0001209191-17-047285#line-2","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":12.43,"price_display":"12.43","price_state":"stated","total_value":12430.0,"total_display":"12,430.00","shares_owned_after":54400.0,"shares_owned_after_display":"54,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-03","filed_date":"2017-08-03","scope":"insider"},{"id":5070787,"accession":"0001209191-17-047285","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-047285","line_url":"/filing/0001209191-17-047285#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":12.28,"price_display":"12.28","price_state":"stated","total_value":12280.0,"total_display":"12,280.00","shares_owned_after":53400.0,"shares_owned_after_display":"53,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-03","filed_date":"2017-08-03","scope":"insider"},{"id":5367051,"accession":"0001415889-17-000623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-17-000623","line_url":"/filing/0001415889-17-000623#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"MetaStat, Inc.","issuer_ticker":"MTST.OB","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"shares_owned_after":49616.0,"shares_owned_after_display":"49,616","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-04","filed_date":"2017-04-06","scope":"insider"},{"id":4540035,"accession":"0001209191-17-018792","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-018792","line_url":"/filing/0001209191-17-018792#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":9.44,"price_display":"9.44","price_state":"stated","total_value":18880.0,"total_display":"18,880.00","shares_owned_after":52400.0,"shares_owned_after_display":"52,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-07","filed_date":"2017-03-07","scope":"insider"},{"id":2181809,"accession":"0001209191-16-155553","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-155553","line_url":"/filing/0001209191-16-155553#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":17000.0,"total_display":"17,000.00","shares_owned_after":50400.0,"shares_owned_after_display":"50,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-15","filed_date":"2016-12-16","scope":"insider"},{"id":2110820,"accession":"0001209191-16-152668","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-152668","line_url":"/filing/0001209191-16-152668#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":7.98,"price_display":"7.98","price_state":"stated","total_value":15960.0,"total_display":"15,960.00","shares_owned_after":48400.0,"shares_owned_after_display":"48,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-30","filed_date":"2016-12-01","scope":"insider"},{"id":2890225,"accession":"0001209191-16-149392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-149392","line_url":"/filing/0001209191-16-149392#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":8.84,"price_display":"8.84","price_state":"stated","total_value":17680.0,"total_display":"17,680.00","shares_owned_after":24500.0,"shares_owned_after_display":"24,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-09","filed_date":"2016-11-10","scope":"insider"},{"id":2151609,"accession":"0001415889-16-007543","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-16-007543","line_url":"/filing/0001415889-16-007543#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"MetaStat, Inc.","issuer_ticker":"MTST.OB","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28342.0,"shares_display":"28,342","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":56684.0,"total_display":"56,684.00","shares_owned_after":29616.0,"shares_owned_after_display":"29,616","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-30","filed_date":"2016-12-05","scope":"insider"},{"id":2211472,"accession":"0001209191-16-139759","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-139759","line_url":"/filing/0001209191-16-139759#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.75,"price_display":"11.75","price_state":"stated","total_value":11750.0,"total_display":"11,750.00","shares_owned_after":22500.0,"shares_owned_after_display":"22,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-02","filed_date":"2016-09-02","scope":"insider"},{"id":2288265,"accession":"0001209191-16-139308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-139308","line_url":"/filing/0001209191-16-139308#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":12.41,"price_display":"12.41","price_state":"stated","total_value":12410.0,"total_display":"12,410.00","shares_owned_after":21500.0,"shares_owned_after_display":"21,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-30","filed_date":"2016-08-31","scope":"insider"},{"id":3129071,"accession":"0001209191-16-138169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-138169","line_url":"/filing/0001209191-16-138169#line-2","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.66,"price_display":"11.66","price_state":"stated","total_value":11660.0,"total_display":"11,660.00","shares_owned_after":20500.0,"shares_owned_after_display":"20,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-22","filed_date":"2016-08-22","scope":"insider"},{"id":3129067,"accession":"0001209191-16-138169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-138169","line_url":"/filing/0001209191-16-138169#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.2,"price_display":"11.20","price_state":"stated","total_value":11200.0,"total_display":"11,200.00","shares_owned_after":19500.0,"shares_owned_after_display":"19,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-19","filed_date":"2016-08-22","scope":"insider"},{"id":2701787,"accession":"0001209191-16-137294","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-137294","line_url":"/filing/0001209191-16-137294#line-2","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.37,"price_display":"11.37","price_state":"stated","total_value":11370.0,"total_display":"11,370.00","shares_owned_after":18500.0,"shares_owned_after_display":"18,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-16","filed_date":"2016-08-16","scope":"insider"},{"id":2701783,"accession":"0001209191-16-137294","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-137294","line_url":"/filing/0001209191-16-137294#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.2,"price_display":"11.20","price_state":"stated","total_value":11200.0,"total_display":"11,200.00","shares_owned_after":17500.0,"shares_owned_after_display":"17,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-16","scope":"insider"},{"id":2595068,"accession":"0001209191-16-136018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-136018","line_url":"/filing/0001209191-16-136018#line-2","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.11,"price_display":"11.11","price_state":"stated","total_value":11110.0,"total_display":"11,110.00","shares_owned_after":16500.0,"shares_owned_after_display":"16,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-09","filed_date":"2016-08-09","scope":"insider"},{"id":2595062,"accession":"0001209191-16-136018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-136018","line_url":"/filing/0001209191-16-136018#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":10.94,"price_display":"10.94","price_state":"stated","total_value":10940.0,"total_display":"10,940.00","shares_owned_after":15500.0,"shares_owned_after_display":"15,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-09","filed_date":"2016-08-09","scope":"insider"},{"id":2319661,"accession":"0001209191-16-135746","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-135746","line_url":"/filing/0001209191-16-135746#line-2","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":10.15,"price_display":"10.15","price_state":"stated","total_value":10150.0,"total_display":"10,150.00","shares_owned_after":14500.0,"shares_owned_after_display":"14,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-04","filed_date":"2016-08-05","scope":"insider"},{"id":2319657,"accession":"0001209191-16-135746","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-135746","line_url":"/filing/0001209191-16-135746#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.77,"price_display":"9.77","price_state":"stated","total_value":9770.0,"total_display":"9,770.00","shares_owned_after":13500.0,"shares_owned_after_display":"13,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-04","filed_date":"2016-08-05","scope":"insider"},{"id":3157757,"accession":"0000899243-16-019805","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-019805","line_url":"/filing/0000899243-16-019805#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"Spring Bank Pharmaceuticals, Inc.","issuer_ticker":"SBPH","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-11","filed_date":"2016-05-12","scope":"insider"},{"id":8784632,"accession":"0001415889-15-002585","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-15-002585","line_url":"/filing/0001415889-15-002585#line-2","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"MetaStat, Inc.","issuer_ticker":"MTST","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":1400.0,"total_display":"1,400.00","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-05","filed_date":"2015-08-06","scope":"insider"},{"id":8784631,"accession":"0001415889-15-002585","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-15-002585","line_url":"/filing/0001415889-15-002585#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"MetaStat, Inc.","issuer_ticker":"MTST","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4100.0,"shares_display":"4,100","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":1107.0,"total_display":"1,107.00","shares_owned_after":19100.0,"shares_owned_after_display":"19,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-05","filed_date":"2015-08-06","scope":"insider"},{"id":8850938,"accession":"0001415889-15-002204","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-15-002204","line_url":"/filing/0001415889-15-002204#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"MetaStat, Inc.","issuer_ticker":"MTST","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.3535,"price_display":"0.35","price_state":"stated","total_value":3535.0,"total_display":"3,535.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-25","filed_date":"2015-06-26","scope":"insider"},{"id":7359687,"accession":"0000950117-10-000372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950117-10-000372","line_url":"/filing/0000950117-10-000372#line-1","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"JAV","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22181.0,"shares_display":"22,181","price_per_share":1.3015,"price_display":"1.30","price_state":"stated","total_value":28868.5715,"total_display":"28,868.57","shares_owned_after":236553.0,"shares_owned_after_display":"236,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-19","filed_date":"2010-03-23","scope":"insider"},{"id":9211756,"accession":"0000950117-10-000379","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950117-10-000379","line_url":"/filing/0000950117-10-000379#line-1","is_derivative":false,"issuer_cik":"0001339402","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"JAV","issuer_name_source":null,"issuer_url":"/issuer/0001339402","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6331.0,"shares_display":"6,331","price_per_share":1.27,"price_display":"1.27","price_state":"stated","total_value":8040.37,"total_display":"8,040.37","shares_owned_after":214372.0,"shares_owned_after_display":"214,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-12","filed_date":"2010-03-26","scope":"insider"},{"id":7424302,"accession":"0000950117-10-000244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950117-10-000244","line_url":"/filing/0000950117-10-000244#line-1","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"JAV","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6331.0,"shares_display":"6,331","price_per_share":1.27,"price_display":"1.27","price_state":"stated","total_value":8040.37,"total_display":"8,040.37","shares_owned_after":194481.0,"shares_owned_after_display":"194,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-12","filed_date":"2010-02-17","scope":"insider"},{"id":3805037,"accession":"0001209191-08-039177","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-039177","line_url":"/filing/0001209191-08-039177#line-1","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"AMEXJAV","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":2.32,"price_display":"2.32","price_state":"stated","total_value":69600.0,"total_display":"69,600.00","shares_owned_after":81493.0,"shares_owned_after_display":"81,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-26","filed_date":"2008-06-26","scope":"insider"},{"id":2939267,"accession":"0001209191-08-030273","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-030273","line_url":"/filing/0001209191-08-030273#line-1","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"AMEXJAV","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41493.0,"shares_display":"41,493","price_per_share":2.41,"price_display":"2.41","price_state":"stated","total_value":99998.13,"total_display":"99,998.13","shares_owned_after":41493.0,"shares_owned_after_display":"41,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-13","filed_date":"2008-05-15","scope":"insider"},{"id":7647427,"accession":"0001209191-07-063065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-063065","line_url":"/filing/0001209191-07-063065#line-2","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"JAV","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7200.0,"shares_display":"7,200","price_per_share":4.4,"price_display":"4.40","price_state":"stated","total_value":31680.0,"total_display":"31,680.00","shares_owned_after":7200.0,"shares_owned_after_display":"7,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-08","filed_date":"2007-11-09","scope":"insider"},{"id":7647426,"accession":"0001209191-07-063065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-063065","line_url":"/filing/0001209191-07-063065#line-1","is_derivative":false,"issuer_cik":"0000050710","issuer_name":"JAVELIN PHARMACEUTICALS, INC","issuer_ticker":"JAV","issuer_name_source":null,"issuer_url":"/issuer/0000050710","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":4.39,"price_display":"4.39","price_state":"stated","total_value":12292.0,"total_display":"12,292.00","shares_owned_after":2800.0,"shares_owned_after_display":"2,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-08","filed_date":"2007-11-09","scope":"insider"},{"id":5443586,"accession":"0001193805-06-001219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-06-001219","line_url":"/filing/0001193805-06-001219#line-1","is_derivative":false,"issuer_cik":"0000880643","issuer_name":"GENTA INC DE/","issuer_ticker":"GNTA","issuer_name_source":null,"issuer_url":"/issuer/0000880643","owner_cik":"0001339402","owner_name":"Driscoll Martin J","owner_url":"/insider/0001339402","role":"Director","officer_title":null,"security_title":"Common Stock, par value $.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":1.46,"price_display":"1.46","price_state":"stated","total_value":21900.0,"total_display":"21,900.00","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-12","filed_date":"2006-05-15","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":39,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":38,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":39},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001566373","name":"F-star Therapeutics, Inc.","url":"/issuer/0001566373","role":"Director, Officer (President and CEO)","n_filings":20,"first_seen":"2016-05-12","last_seen":"2020-11-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001404943","name":"MetaStat, Inc.","url":"/issuer/0001404943","role":"Director","n_filings":4,"first_seen":"2015-06-26","last_seen":"2017-04-06"},{"type":"issuer","type_label":"ISSUER","cik":"0000050710","name":"JAVELIN PHARMACEUTICALS, INC","url":"/issuer/0000050710","role":"Director, Officer (Chief Executive Officer)","n_filings":6,"first_seen":"2007-11-09","last_seen":"2010-03-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000880643","name":"GENTA INC DE/","url":"/issuer/0000880643","role":"Director","n_filings":1,"first_seen":"2006-05-15","last_seen":"2006-05-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001339402","retrieved_at":"2026-08-22T01:22:24+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}